// App-Quantinova.ai

533 : Assessment of Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Tofacitinib: Data from an Open-Label Long-Term Extension Study over 3 Years

Researchers

Presenter

  • Dsire van der Heijde

Principal Investigators

  • Jrgen Wollenhaupt

  • Stanley B Cohen

  • Sander Strengholt

  • Ketti Terry

  • Ryan DeMasi

  • Kenneth Kwok

  • Irina Lazariciu

  • Lisy Wang

Medical Centers

  • Leiden University Medical Centre, Leiden, Netherlands

  • Schoen-Klinik Hamburg-Eilbek Teaching Hospital of the University of Hamburg, Hamburg, Germany

  • Metroplax Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX

  • Pfizer Inc., Capelle a/d IJssel, Netherlands

  • Pfizer, Groton, CT

  • Pfizer Inc, Collegeville, PA

  • Pfizer Inc, New York, NY

  • Quintiles, Saint-Laurent, QC, Canada

Locations

  • Netherlands

  • Germany

  • United States

  • Canada

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Tasocitinib

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • III

Study Id's

  • NCT01039688

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved